Skip to contentN
NU Skin Enterprises, Inc.
N
NUSNU Skin Enterprises, Inc. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$445.55M$445.55Mderived−8.8% vs Q4 2023 Net Income-$36.11M-$36.11MderivedN/M vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NU Skin Enterprises, Inc. · CIK 1021561 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$279,147,000−20.8% Operating Incomederived-$53,081,000N/M Operating Cash Flowderived$25,785,000−52.4% Free Cash Flowderived$13,202,000−60.9% Margins · derivedGross margin62.7%−9.5 pt vs Q4 2023
Operating margin-11.9%−15.2 pt vs Q4 2023
Net margin-8.1%−9.6 pt vs Q4 2023
ended Dec 31, 2024 · filed Feb 14, 2025 · 45 d after period end